Transactions
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 | Kiliaro Group AB | Peter Gunnar Werme | Chairman of the Board of Directors | Subscription | 166 667 | 0,9 | SEK | 150 000,3 | 2024-07-02 |
| 2024-07-03 | Svenska Aerogel Holding AB (publ) | Mårten Hellberg | Member of the Board of Directors | Acquisition | 487 804 | 0,123 | SEK | 59 999,892 | 2024-07-02 |
| 2024-07-04 | Svenska Aerogel Holding AB (publ) | Joakim Wanner | Other member of the company's administrative, management or supervisory body | Acquisition | 607 715 | 0,123 | SEK | 74 748,945 | 2024-07-02 |
| 2024-07-04 | Svenska Aerogel Holding AB (publ) | Håkan Burtsoff | Other member of the company's administrative, management or supervisory body | Acquisition | 599 219 | 0,123 | SEK | 73 703,937 | 2024-07-02 |
| 2024-07-03 | IMPLANTICA AG | Peter Forsell | Chief Executive Officer (CEO)/Managing Directory | Gift given | 510 000 | 0 | SEK | 0 | 2024-06-30 |
| 2024-07-03 | AcuCort AB | Anna Eriksrud | Member of the Board of Directors | Allotment | 130 000 | 0,11 | SEK | 14 300 | 2024-07-01 |
| 2024-07-04 | Alzinova AB | Per-Goran Gillberg | Member of the Board of Directors | Acquisition | 111 111 | 0,9 | SEK | 99 999,9 | 2024-07-01 |
| 2024-07-03 | Raytelligence AB | Daisy Arnold | Other senior executive | Disposal | 75 000 | 1,47 | SEK | 110 250 | 2024-06-27 |
| 2024-07-03 | Raytelligence AB | Daisy Arnold | Other senior executive | Disposal | 50 000 | 2,35 | SEK | 117 500 | 2024-07-02 |
| 2024-07-03 | Calliditas Therapeutics AB | Richard Philipson | Other member of the company's administrative, management or supervisory body | Disposal | 23 676 | 205,56 | SEK | 4 866 838,56 | 2024-06-30 |
| 2024-07-03 | Calliditas Therapeutics AB | Richard Philipson | Other member of the company's administrative, management or supervisory body | Disposal | 27 209 | 205,49 | SEK | 5 591 177,41 | 2024-07-01 |
| 2024-07-03 | Calliditas Therapeutics AB | Richard Philipson | Other member of the company's administrative, management or supervisory body | Acquisition | 50 885 | 0 | SEK | 0 | 2024-06-30 |
| 2024-07-03 | Calliditas Therapeutics AB | Sandra Boström Frithiof | Other senior executive | Disposal | 5 682 | 205,56 | SEK | 1 167 991,92 | 2024-06-30 |
| 2024-07-03 | Calliditas Therapeutics AB | Sandra Boström Frithiof | Other senior executive | Acquisition | 12 212 | 0 | SEK | 0 | 2024-06-30 |
| 2024-07-03 | Calliditas Therapeutics AB | Sandra Boström Frithiof | Other senior executive | Disposal | 6 530 | 205,49 | SEK | 1 341 849,7 | 2024-07-01 |
| 2024-07-04 | Calliditas Therapeutics AB | Lars Stubberud | Other member of the company's administrative, management or supervisory body | Acquisition | 12 212 | 0 | SEK | 0 | 2024-06-30 |
| 2024-07-04 | Calliditas Therapeutics AB | Lars Stubberud | Other member of the company's administrative, management or supervisory body | Disposal | 6 530 | 205,49 | SEK | 1 341 849,7 | 2024-07-01 |
| 2024-07-04 | Calliditas Therapeutics AB | Lars Stubberud | Other member of the company's administrative, management or supervisory body | Disposal | 5 682 | 205,56 | SEK | 1 167 991,92 | 2024-06-30 |
| 2024-07-03 | NYAB AB | Magnus Granljung | Deputy CEO/Deputy Managing Director | Disposal | 5 000 000 | 5 | SEK | 25 000 000 | 2024-07-02 |
| 2024-07-03 | NYAB AB | Johan Larsson | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 40 000 | 6,96 | SEK | 278 400 | 2024-07-02 |